On February 2, 2026, U.S. District Court for the Eastern District of Pennsylvania Judge Joshua D. Wolson, sitting by designation in the U.S. District Court for the District of Delaware, made several key summary judgment rulings in advance of trial in Arbutus Biopharma Corporation and Genevant Sciences GmbH (collectively “Arbutus”) v. Moderna, Inc. and ModernaTx, Inc.
Whether the plaintiff has adequately identified the trade secrets that have allegedly been misappropriated is a commonly litigated and critical issue under the Defend Trade Secrets Act (DTSA). Unlike other types of intellectual property—such as patents, copyrights, and trademarks—where the property has already been identified and registered, trade secrets by definition are secret and cannot be identified publicly without destroying the subject matter of the plaintiff’s legal claim. Yet defendants still need to know what secrets they have allegedly misappropriated, and the court needs to know what the case is about.
A recent U.S. Court of Appeals for the Third Circuit ruling upholding the federal Inflation Reduction Act (IRA)’s drug price negotiation program has been appealed to the U.S. Supreme Court, one of many challenges to the Act’s constitutionality. The IRA requires drugmakers to sell selected patented drugs to the government for its Medicare Parts B & D programs at a stipulated “maximum fair price”. If they don’t agree to these prices, then they face tax penalties on sales of the drug exceeding their profits from it, or the exclusion of all their drugs from Medicare and Medicaid purchases. This would foreclose access to up to 160 million patients, accounting for around 40% of US prescription drug spending or 20% of global prescription drug spending. US government purchases are valued at $200 billion annually.
There are lots of familiar recommendations to make U.S. businesses more competitive globally. All are valid, but none are particularly creative or original. One solution that hasn’t been pursued is not only simple, a variation of it has been implemented by America’s largest and most aggressive economic competitor: remove the filing fees for inventors and intellectual property (IP)creators under 18.
“Run, don’t walk!” has become a familiar call across TikTok and Instagram, signaling that a new budget-friendly “dupe” has landed on store shelves. What was once quiet bargain-hunting has turned into a celebrated online trend, where creators openly compare low-cost look-alikes to premium products. But, as dupe culture surges, brand owners are increasingly turning to trademark and trade dress law to protect what they argue is far more than just a logo, but their brand identity.
Sharing information about an invention is not an option. With patents, disclosure is a requirement which benefits the inventor, other inventors and society. When and how an invention is shared makes a huge difference. Disclosing information and sharing the right to practice it are not the same. The Patent Bay, a new patent platform from a Swedish company that believes some patent owners are hoarders, is looking to change how patents are shared and used.
In the most recent episode of IP Innovators, host Steve Brachmann sits down with Stephanie Curcio, CEO and co-founder of NLPatent, to unpack how AI is reshaping prosecution, search, and the overall workflow across patent professions. Curcio, who began her career in traditional patent drafting and prosecution, explains how early concept-based AI search tools convinced her the profession was on the verge of a seismic shift.
The Supreme Court rejected equitable defenses of laches in infringement suits, reasoning that by enacting a statute of limitation, Congress left no statutory “gap” for equitable judgments on timeliness. See Petrella v. Metro-Goldwyn-Mayer (2014), and SCA Hygiene Prods. v. First Quality Baby Prods (2017). These precedential holdings should have also governed U.S. Court of Appeals for the Federal Circuit (CAFC) decisions on prosecution laches in Hyatt v. Hirshfeld (2021) and in Hyatt v. Stewart (2025), particularly after the multiple briefings in the Hyatt case on the binding effect of such holdings. Yet, nowhere in these decisions can one find any reasons why the principles in SCA Hygiene and Petrella should be inapplicable for precluding prosecution laches.
Much of the focus on generative artificial intelligence (GenAI) has been on training data ingestion—the moment when AI “steals” from creators. But legally, that’s not where the real fight should be. Decades of legal precedent—from search engines to image?scanning to streaming media—already give us a roadmap. No new formulation of copyright law by Congress, as suggested by some academics, is necessary. By considering these seven unique aspects of GenAI systems, copyright analysis is actually easy.
Commerce Secretary Howard Lutnick is urging the White House to turn a proposal he floated into an Executive Order that would weaken the economy and cost the government tens of billions of dollars in foregone tax revenue. It’s bad policy, and even worse politically. The Trump Administration would be wise to reject it. Secretary Lutnick is convinced that the government is being short-changed when academic institutions make patentable inventions under federal grants, which are primarily licensed to entrepreneurial small companies that take great risk and expense to turn them into real-world products. The Secretary wants the government to seize 50% of the royalties that universities receive when resulting products are sold—sales that bolster our economy while promoting public well-being.
On day one of 2026, we asked IP stakeholders to give their predictions for the year ahead on the IP front. From copyright and fair use to patent reform and USPTO operations, here is what they had to say about what to expect in the New Year.
While being realistic and practical in IP law is usually prudent, it’s a helpful exercise to now and then articulate one’s fantasies for a perfect world in order to gauge what topics come up most often. This year, as in years past, clarity on patent eligibility law remains high, while protections for an improvement of AI tools takes second. Some of the wishes below have little chance of coming true in 2026, but others may be granted—here is what our participants would like to see happen for IP in the new year.
Global litigation over standard essential patents (SEPs) is facing new strategies by implementers, mainly related to venue selection. There is an increasing risk of foreign decisions aimed at interfering with decisions on infringement of patents granted and issued in foreign jurisdictions – in clear tension with the territoriality principle. There is also a trend of abuse of process in the selection of venues within specific countries aimed at creating obstacles and delaying remedies and effective protection for national IP rights.
As 2025 draws to a close, the intellectual property ecosystem faces a wave of transformative changes driven by artificial intelligence (AI) and evolving legislative priorities. From sweeping federal proposals aimed at harmonizing AI governance and overriding state laws, to new copyright and media integrity measures designed to address deepfakes and transparency, and finally to renewed momentum behind patent eligibility and Patent Trial and Appeal Board (PTAB) reform, these developments signal a pivotal moment for innovators, rights holders, and policymakers alike. This article explores three critical fronts shaping the future of IP: federal AI legislation and executive preemption, copyright accountability and media integrity, and the year-end outlook for patent reform—each redefining the balance between innovation, protection, and compliance.
For Section 337 investigations before the U.S. International Trade Commission (ITC), 2025 was a year of contrasts. As one example, the Federal Circuit’s long-awaited decision in Lashify, Inc. v. ITC reduced the burden for satisfying Section 337’s domestic industry requirement, under which ITC complainants must show adequate U.S. investments in practicing or exploiting the asserted intellectual property rights. But this lower threshold did not immediately result in increased Section 337 complaint filings. For much of 2025, uncertainty concerning U.S. trade policy and federal government operations likely depressed ITC complaint filings.